Dual-action GIP/GLP-1 — the most effective weight loss medication available.
Quick answer: Compounded tirzepatide injectable is a dual GIP and GLP-1 receptor agonist prescribed for weight loss that targets both appetite and metabolism simultaneously. The medication is dispensed only after required lab work and a review by a licensed clinician. Treatment includes a compounded tirzepatide vial, injection supplies, a guided dose titration schedule, provider monitoring, and monthly home delivery.
Free shipping · cancel your renewal anytime (see Terms) · dispensed medication is not refundable
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist that targets two hormonal pathways for weight loss. In the SURMOUNT clinical trials, it produced up to 22.5% body weight loss — making it the most effective weight loss medication ever studied. It works on both appetite and metabolism simultaneously.
Unlike single-action GLP-1 drugs, tirzepatide activates both GIP and GLP-1 receptors. GIP (glucose-dependent insulinotropic polypeptide) enhances fat metabolism and improves insulin sensitivity, while GLP-1 reduces appetite and slows gastric emptying. This dual mechanism produces superior weight loss results compared to semaglutide alone.
Take our 2-minute quiz to see if Compounded Tirzepatide Injectable is right for you.
Start Your Free Assessment →